as on October 18, 2025 at 1:29 am IST
Day's Low
Day's High
0.75%
Downside
10.80%
Upside
52 Week's Low
52 Week's High
72.36%
Downside
37.68%
Upside
Check Cellectis S.a. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$421.3M
EPS (TTM)
-0.61
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
0PEG Ratio
0EBITDA
-33.0M
Revenue (TTM)
63.4M
Profit Margin
-93.00%
Return On Equity TTM
3900.00%
Compare market cap, revenue, PE, and other key metrics of Cellectis S.a. with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
---|---|---|---|---|---|
BUY | $421.3M | -79.78% | NA | -93.00% | |
BUY | $63.1B | 231.27% | -505.15 | -12.96% | |
NA | $36.7B | NA | NA | -3.89% | |
BUY | $104.8B | 91.13% | 29.04 | 31.86% | |
BUY | $60.3B | -3.62% | 14.35 | 31.37% |
The Cellectis S.a. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Cellectis S.a. investment value today
Current value as on today
₹2,14,268
Returns
₹1,14,268
(+114.27%)
Returns from Cellectis S.a. Stock
₹1,09,474 (+109.47%)
Dollar Returns*
₹4,794 (+4.79%)
Based on 14 analysts
85.71%
Buy
14.29%
Hold
0.00%
Sell
Based on 14 analysts, 85.71% of analysts recommend a 'BUY' rating for Cellectis S.a.. Average target price of $5.8
Get share price movements and forecasts by analysts on Cellectis S.a..
What analysts predicted
31.38%UPSIDE
Target Price
$5.8
Current Price
$3.98
Analyzed by
14 Analysts
Target
$5.80
Cellectis S.a. target price $5.8, a slight upside of 31.38% compared to current price of $3.98. According to 14 analysts rating.
Search interest for Cellectis S.a. Stock has increased by 213% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:213% versus previous 30 day period
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Best in 1 Year
In the last 1 year, CLLS has outperformed top 5 stocks with highest market-cap in its industry
Revenue Rich
Revenue is up for the last 2 quarters, 10.65M → 16.93M (in $), with an average increase of 37.1% per quarter
Against Peers
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 149.6% return, outperforming this stock by 75.8%
Profit Down
Netprofit is down for the last 3 quarters, 5.92M → -24.03M (in $), with an average decrease of 219.4% per quarter
Price Dip
In the last 7 days, CLLS stock has moved down by -10.0%
Organisation | Cellectis S.a. |
Headquarters | 8, rue de la Croix Jarry, Paris, France, 75013 |
Industry | Health Technology |
CEO | Dr. Andre Choulika Ph.D. |
E-voting on shares | Click here to vote |
Name | Title |
---|---|
Dr. Andre Choulika Ph.D. | Co-Founder, CEO & Director |
Dr. David J. Sourdive Ph.D. | Co-Founder, Deputy CEO, Executive VP of CMC & Manufacturing and Director |
Mr. Arthur Stril | CFO & Chief Business Officer |
Mr. Stephan Reynier M.Sc. | Chief Regulatory & Pharmaceutical Compliance Officer |
Valerie Cros | Principal Financial Officer & Principal Accounting Officer |
Mr. Jean Charles Epinat Ph.D. | Chief Technological Officer |
Dr. Philippe Duchateau Ph.D. | Chief Scientific Officer |
Ms. Marie-Bleuenn Terrier | General Counsel & Secretary of the Board of Directors |
Pascalyne Wilson | Director of Communications |
Ms. Kyung Nam-Wortman | Executive VP & Chief Human Resources Officer |
Cellectis S.a. share price today is $3.98 as on at the close of the market. Cellectis S.a. share today touched a day high of $4.41 and a low of $3.95.
Cellectis S.a. share touched a 52 week high of $5.48 on and a 52 week low of $1.1 on . Cellectis S.a. stock price today i.e. is closed at $3.98,which is 27.37% down from its 52 week high and 261.82% up from its 52 week low.
Cellectis S.a. market capitalisation is $0.00T as on .
Indian investors can start investing in Cellectis S.a. (CLLS) shares with as little as ₹87.954 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹879.54 in Cellectis S.a. stock (as per the Rupee-Dollar exchange rate as on ).
Based on Cellectis S.a. share’s latest price of $3.98 as on October 18, 2025 at 1:29 am IST, you will get 2.5126 shares of Cellectis S.a.. Learn more about
fractional shares .
Cellectis S.a. stock has given -79.78% share price returns and 21.02% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?